Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.4 |
mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.4 |
mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.4 |
mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.041 | 0.4 |
mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.4 |